Related Experiment Video
Updated: Oct 2, 2026

Utilizing pHluorin-tagged Receptors to Monitor Subcellular Localization and Trafficking
Published on: March 16, 2017
Subcellular localization of NAD(P)H:quinone oxidoreductase 1 in human cancer cells
Shannon L Winski1, Yiannis Koutalos, David L Bentley
1Department of Pharmaceutical Sciences, University of Colorado Health Sciences Center, Denver, Colorado 80017, USA.
Abstract:
NAD(P)H:quinone oxidoreductase 1 (NQO1) is implicated in both chemoprevention and bioactivation of DNA-damaging antitumor agents. NQO1 is mainly cytosolic, but distribution in other cellular compartments, particularly in tumor cells, is poorly defined. Nuclear NQO1 in HT29 human colon carcinoma and H661 human non-small cell lung cancer cells was observed using both confocal microscopy and immunoelectron microscopy. NQO1 was not detected in mitochondria, golgi, or endoplasmic reticulum. In addition, purified intact nuclei from HT29 cells contained immunoreactive NQO1, which was catalytically active as determined by conventional activity assay. In summary, we have confirmed the presence of nuclear NQO1, which has implications for chemoprotection and bioactivation of DNA-damaging antitumor agents.
Insights
Nuclear NAD(P)H:quinone oxidoreductase 1 (NQO1) was identified in human cancer cells. This finding impacts understanding of chemoprevention and bioactivation of antitumor agents.
Area of Science:
- Biochemistry
- Cell Biology
- Cancer Research
Background:
- NAD(P)H:quinone oxidoreductase 1 (NQO1) plays a dual role in chemoprevention and bioactivation of antitumor agents.
- The cellular localization of NQO1, particularly within tumor cells, is not fully understood, with a primary known cytosolic distribution.
Purpose of the Study:
- To investigate the presence and location of NQO1 in the nucleus of human cancer cells.
- To determine if nuclear NQO1 retains catalytic activity.
Main Methods:
- Confocal microscopy and immunoelectron microscopy were used to visualize NQO1 in HT29 colon carcinoma and H661 non-small cell lung cancer cells.
- Purified intact nuclei from HT29 cells were analyzed for NQO1 presence and activity.
Main Results:
- Nuclear NQO1 was detected in HT29 and H661 cancer cells.
- NQO1 was not found in mitochondria, Golgi apparatus, or endoplasmic reticulum.
- Purified nuclei contained catalytically active NQO1.
Conclusions:
- The study confirms the presence of nuclear NQO1 in human cancer cells.
- The nuclear localization of NQO1 has significant implications for its roles in chemoprotection and the bioactivation of DNA-damaging antitumor drugs.
Related Concept Videos
The Nucleolus
Nuclear Protein Sorting
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...
Nuclear Localization Signals and Import
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Oxidation of Phenols to Quinones
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox property is crucial in...
